I-Corps: A chip-based nano-opto-fluidic biosensor

Keyphrases

1. Chip-based 100%
2. Optofluidic Sensor 100%
3. Protein Biomarkers 50%
4. I-Corps 50%
5. Sample Pretreatment 50%
6. Market Potential 50%
7. Cardiovascular Disease Diagnosis 25%
8. Biosensor Technology 25%
9. Highly Reliable 25%
10. Optical Measurement 25%
11. Reducing Treatment 25%
12. Blood Cells 25%
13. Thin Metal Films 25%
14. Molecular Detection 25%
15. Early Screening 25%
16. Complex Samples 25%
17. Hospital Facilities 25%
18. Heart Disease Diagnosis 25%
19. System-on-chip 25%
20. Detection Area 25%
21. Troponin 25%
22. Label-free Biosensor 25%
23. Diagnostic Monitoring 25%
24. Reliable Detection 25%
25. Clinical Control 25%
26. Point-of-care Biosensor 25%
27. Point-of-care Diagnostics 25%
28. Patient Monitoring 25%
29. Nanoscale Structure 25%
30. Facility Monitoring 25%
31. Point-of-care 25%
32. Cost-effective Diagnosis 25%
33. Cardiac Biomarkers 25%
34. Diagnostic Research 25%
35. High-throughput Detection 25%
36. Assisted Living Facilities 25%
37. Biomarker Analysis 25%
38. Point-of-care Technology 25%
39. Breast Milk Bank 25%
40. Fluid Handling 25%
41. Whole Blood 25%
42. Early Detection 25%
43. High-throughput 12%
44. Pharmaceutical Industry 12%
45. Laboratory Testing 12%
46. Clinical Diagnosis 12%
47. Ease of Operation 12%
48. Clinical Treatment 12%
49. Personalized Medicine 12%
50. Cardiovascular Disease 12%
51. Biotechnology Industry 12%
52. Life Sciences 12%
53. Science Studies 12%
54. Biological Media 12%
55. Innovative Applications 12%
56. Commercial Potential 12%
57. Optical Detection System 12%
58. Impact Review 12%
59. Sample Preparation 12%
60. Treatment Costs 12%
61. Review Criteria 12%
62. Healthcare Facilities 12%
63. Multiple Biomarkers 12%
64. On-a-chip 12%
65. Early Diagnosis 12%
66. Microfluidics 12%
67. Patient Survival 12%
68. On chip 12%
69. Commercial Application 12%
70. Conventional Biomarkers 12%
71. High Sensitivity 12%
72. Drug Discovery 12%
73. Myocardial Infarction 12%
74. Diagnosis Treatment 12%
75. Detection Method 12%
76. Clinical Investigator 12%